Evidence map›Paper›PMID 25330298›Full record

ArticleThe Journal of investigative dermatology2015

Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita.

Hiroaki Iwata, Elena Pipi, Nicole Möckel, Peter Sondermann, Artem Vorobyev, Nina van Beek, Detlef Zillikens, Ralf J Ludwig

Open access · bronzeAbstract readLetter
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Mechanisms of Autoantibody-Induced Pathology.Frontiers in immunology · 2017
    Review
  7. Review
  8. Review
  9. Fc gamma receptors: glycobiology and therapeutic prospects.Journal of inflammation research · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hiroaki IwataDepartment of Dermatology, University of Lübeck, Lübeck, Germany.
Elena PipiDepartment of Dermatology, University of Lübeck, Lübeck, Germany.
Nicole MöckelDepartment of Dermatology, University of Lübeck, Lübeck, Germany.
Peter SondermannSuppreMol GmbH, Munich, Germany.
Artem VorobyevDepartment of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Nina van BeekDepartment of Dermatology, University of Lübeck, Lübeck, Germany.
Detlef ZillikensDepartment of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany.
Ralf J LudwigDepartment of Dermatology, University of Lübeck, Lübeck, Germany; Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany. Electronic address: Ralf.Ludwig@uksh.de.
University of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ProgressionAnimalsAntigen-Antibody ComplexDisease Models, AnimalEpidermolysis Bullosa AcquisitaHumansMiceReactive Oxygen SpeciesReceptors, IgGRecombinant ProteinsTreatment OutcomeAntigen-Antibody ComplexReactive Oxygen SpeciesReceptors, IgGRecombinant Proteins

Identifiers

PMID25330298
OpenAlexW2015598465

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.